Urticaria
📧 Sign up to get email alerts when something new happens for Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria [Phase 3]
This Phase III study investigates cetirizine hydrochloride injection for acute urticaria and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Treatment Options for Chronic Urticaria [Phase 2]
Phase 2 clinical trial evaluating treatment options for chronic urticaria; current status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: GI Symptoms in Infants Fed Goat Milk-based Infant Formula
Clinical trial update on GI symptoms in infants fed goat milk-based infant formula. The study has completed and assessed stool patterns, ski…
-
FDA approval · 2024-11-26FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) to expand the label for the treatment of urticaria (hive…
-
FDA approval · 2024-11-15FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) by Kenvue Brands LLC. The approval adds or expands the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-13FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Children's Zyrtec (cetirizine hydrochloride) by Kenvue Brands LLC. The approval pertains to a mo…
-
FDA approval · 2024-10-03FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Indoco Remedies Limited)
FDA approved Indoco Remedies Limited's original application for cetirizine hydrochloride, granting approval for a generic antihistamine prod…
-
FDA approval · 2024-08-15FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) filed by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147) [Phase 4]
Phase 4 trial comparing continuous dosing of Aerius (cetirizine) to as-needed dosing in chronic idiopathic urticaria. The study has complete…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg [Phase 1]
A Phase 1 relative bioavailability study comparing cetirizine HCl gummy 10 mg to cetirizine HCl oral tablets 10 mg, with status not yet recr…
-
FDA approval · 2024-05-22FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC., indicating an approved post-approval c…
-
FDA approval · 2024-03-28FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) by Kenvue Brands LLC. The approval covers cetirizine…
-
FDA approval · 2024-03-20FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved a generic diphenhydramine hydrochloride product through an Original Application (ANDA 218448) by Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children [Phase 4]
Phase 4 study exploring optimal cetirizine dosing for allergic diseases in Chinese children.
-
CLINICAL_TRIALS trial_result · 2024-02-21Clinical Trial Update: Antiplatelet Therapy in Chronic Urticaria [Phase 2]
Phase 2 clinical trial update investigating antiplatelet therapy for chronic urticaria.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria [Phase 3]
Pilot Phase III trial of JDP-205 IV injection for acute urticaria has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria [Phase 2]
Phase 2 trial assessing AK002 for antihistamine-resistant chronic urticaria has completed with posted results in 2024.
-
FDA approval · 2024-01-04FDA Approved: ALLERGY RELIEF — Supplemental Application (WALMART INC. (see also Equate))
FDA approved a supplemental application for ALLERGY RELIEF containing fexofenadine HCl, manufactured by Walmart Inc.
-
FDA approval · 2023-12-01FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application to expand ZYRTEC HIVES labeling for the treatment of urticaria (hives) with cetirizine hydrochloride…
-
FDA approval · 2023-10-13FDA Approved: LORATADINE — Supplemental Application (Wal-Mart Stores, Inc)
The FDA approved a supplemental application for loratadine submitted by Wal-Mart Stores, Inc. for an existing loratadine product.
-
FDA approval · 2023-08-17FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for hydroxyzine hydrochloride from Rising Pharma Holdings, Inc., confirming a generic antihistamine pro…
-
FDA approval · 2023-08-01FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) by Chattem, Inc. The product is indicated fo…
-
FDA approval · 2023-07-28FDA Approved: LORATADINE — Original Application (Camber Consumer Care Inc)
The FDA approved Camber Consumer Care Inc's loratadine product via an Original Application (ANDA211718), providing a generic loratadine opti…
-
EMA approval · 2023-06-01EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
The EMA has authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria indications in the European Union.
-
FDA approval · 2023-05-25FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin RediTabs (loratadine) to introduce a new dosage form for Bayer HealthCare LLC.